First Citizens BancShares Inc vs McKesson Corporation — how do they compare? First Citizens BancShares Inc trades at $2,256.93 (market cap $25.04B), while McKesson Corporation trades at $895.52 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 4.2× First Citizens BancShares Inc's market cap, and McKesson Corporation pays the higher dividend (0.42%). Which is the better fit depends on your goals.
| FCNCA | MCK | |
|---|---|---|
Market Cap | $25.04B | $105.14B |
Sector | Sector/Thematic | Health |
52-Week High | $2.25K | $995.69 |
52-Week Low | $1.64K | $659.01 |
Dividend Yield | 0.37% | 0.42% |
Enterprise Value | — | $111.67B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
McKesson (MCK) trades at $879.87, up 1.18% today, with strong momentum from recent earnings beats and raised guidance. The stock shows bullish technical signals, supported by robust revenue growth and solid cash flow generation. Recent news highlights strength in specialty drugs and oncology, driving positive sentiment.
Outlook remains favorable with a consensus price target of $990.67, though thin profit margins and high liabilities pose risks. Continued execution on growth initiatives and cost discipline are key for sustained upside, while macroeconomic pressures and competitive dynamics require monitoring.
Trailing returns across standard periods
Latest headlines on both assets
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →